Aaron Kantoff serves as Executive at Centessa Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Aaron Kantoff has executed 7 insider transactions totaling $208.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 28, 2025 involved transacting 88,281 shares valued at $0.
Aaron Kantoff currently holds 88,281 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Kantoff has been a net buyer of CNTA stock. They have purchased $208.8K and sold $0 worth of shares.
Aaron Kantoff's most recent insider trade was on Oct 28, 2025, when they sold 88,281 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 5, 2025 | TRML | $94.6K | Option Exercise | 10,000 | $9.46 | Discretionary |
| Sep 5, 2025 | TRML | $4.9K | Option Exercise | 37,890 | $0.13 | Discretionary |
| Oct 24, 2023 | TRML | $89.0K | Purchase | 7,500 | $11.86 | Discretionary |
| Oct 19, 2023 | TRML | $0 | Award | 37,891 | $N/A | Discretionary |
| Nov 18, 2021 | CNTA | $119.9K | Purchase | 10,000 | $11.99 | Discretionary |